{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:53:00Z","timestamp":1781671980839,"version":"3.54.5"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008967","name":"Philipps-Universit\u00e4t Marburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008967","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Post-COVID syndrome is common and associated with substantial morbidity, yet its pathophysiology and predictors of disease course remain incompletely understood. This study aimed to quantify symptom burden in patients attending a post-COVID outpatient clinic and to evaluate associations with pulmonary function parameters, exercise capacity, and circulating biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The prospective CCHROMO cohort collects longitudinal clinical data, detailed pulmonary function testing, and blood samples from patients with persistent symptoms following SARS-CoV-2 infection, with planned follow-up of up to three years. We present an interim analysis of 253 patients contributing 561 study visits (median follow-up 273 days after COVID-19 diagnosis; interquartile range [IQR] 177\u2013332). Assessments included standardized symptom questionnaires, spirometry, inspiratory muscle strength testing, cardiopulmonary exercise testing (CPET), and serum biomarker measurements reflecting inflammation as well as epithelial and endothelial injury.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      At study entry, the most prevalent symptoms were fatigue (84.6% reporting at least moderate severity), dyspnoea (70.3%), headache (69.8%), and neurocognitive impairment (66.4%). Spirometric values were within normal ranges in most participants. In contrast, reduced inspiratory muscle strength was observed in 54.8% of visits, and impaired exercise capacity on CPET in 28.8%. Correlations between symptom severity, pulmonary function, CPET parameters, and circulating biomarkers were weak. Serum club cell protein-16 (CC-16) levels were lower in patients with severe fatigue (median [IQR] 6.6 [4.7\u20138.4] ng\/mL) compared with those without fatigue (7.6 [6.3\u201310.1] ng\/mL;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.039).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with post-COVID syndrome show a high and persistent symptom burden, frequently accompanied by reduced inspiratory muscle strength and impaired exercise capacity despite preserved spirometry. Associations between symptoms, physiological measures, and biomarkers were weak and suggest heterogenous post-COVID manifestations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>German Clinical Trials Register (DRKS00022475, Date of Registration 2020-07-27).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-026-04365-1","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:16:00Z","timestamp":1781658960000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Symptom burden, lung function, exercise tolerance and inflammation in patients post COVID-19: results from the prospective COVID-19 Chronic Morbidity (CCHROMO) study"],"prefix":"10.1186","volume":"26","author":[{"given":"Carla","family":"Bellinghausen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"Gr\u00fcnewaldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Azem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelius","family":"Lask","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Seeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Hafner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J. G. T.","family":"Vehreschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias Manuel","family":"Appel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gernot","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"4365_CR1","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","volume":"22","author":"JB Soriano","year":"2022","unstructured":"Soriano JB, Murthy S, Marshall JC, et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102\u20137.","journal-title":"Lancet Infect Dis"},{"key":"4365_CR2","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/infdis\/jiac136","volume":"226","author":"C Chen","year":"2022","unstructured":"Chen C, Haupert SR, Zimmermann L, et al. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review. J Infect Dis. 2022;226:1593\u2013607.","journal-title":"J Infect Dis"},{"key":"4365_CR3","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1001\/jama.2022.18931","volume":"328","author":"S Wulf Hanson","year":"2022","unstructured":"Global Burden of Disease Long COVID Collaborators, Wulf Hanson S, Abbafati C, et al. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328:1604.","journal-title":"JAMA"},{"key":"4365_CR4","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1038\/s41467-022-30836-0","volume":"13","author":"EJ Thompson","year":"2022","unstructured":"Thompson EJ, Williams DM, Walker AJ, et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022;13:3528.","journal-title":"Nat Commun"},{"key":"4365_CR5","doi-asserted-by":"publisher","first-page":"e1211","DOI":"10.1002\/hsr2.1211","volume":"6","author":"P Iqbal","year":"2023","unstructured":"Iqbal P, Ata F, Chaudhry H, et al. Post-COVID-19-associated multiorgan complications or long COVID with literature review and management strategy discussion: A meta-analysis. Health Sci Rep. 2023;6:e1211.","journal-title":"Health Sci Rep"},{"key":"4365_CR6","doi-asserted-by":"publisher","first-page":"1112383","DOI":"10.3389\/fpubh.2023.1112383","volume":"11","author":"N Yuan","year":"2023","unstructured":"Yuan N, Lv Z-H, Sun C-R, et al. Post-acute COVID-19 symptom risk in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Front Public Health. 2023;11:1112383.","journal-title":"Front Public Health"},{"key":"4365_CR7","doi-asserted-by":"publisher","first-page":"100899","DOI":"10.1016\/j.eclinm.2021.100899","volume":"36","author":"FM Iqbal","year":"2021","unstructured":"Iqbal FM, Lam K, Sounderajah V, et al. Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis. EClinicalMedicine. 2021;36:100899.","journal-title":"EClinicalMedicine"},{"key":"4365_CR8","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1136\/bjsports-2020-102596","volume":"54","author":"RM Barker-Davies","year":"2020","unstructured":"Barker-Davies RM, O\u2019Sullivan O, Senaratne KPP, et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med. 2020;54:949\u201359.","journal-title":"Br J Sports Med"},{"key":"4365_CR9","doi-asserted-by":"publisher","first-page":"5185","DOI":"10.3390\/ijerph19095185","volume":"19","author":"S Fugazzaro","year":"2022","unstructured":"Fugazzaro S, Contri A, Esseroukh O, et al. Rehabilitation Interventions for Post-Acute COVID-19 Syndrome: A Systematic Review. Int J Environ Res Public Health. 2022;19:5185.","journal-title":"Int J Environ Res Public Health"},{"key":"4365_CR10","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1126\/science.abm8108","volume":"375","author":"M Merad","year":"2022","unstructured":"Merad M, Blish CA, Sallusto F, et al. The immunology and immunopathology of COVID-19. Science. 2022;375:1122\u20137.","journal-title":"Science"},{"key":"4365_CR11","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","volume":"23","author":"C Phetsouphanh","year":"2022","unstructured":"Phetsouphanh C, Darley DR, Wilson DB, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23:210\u20136.","journal-title":"Nat Immunol"},{"key":"4365_CR12","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.immuni.2022.01.017","volume":"55","author":"B Vijayakumar","year":"2022","unstructured":"Vijayakumar B, Boustani K, Ogger PP, et al. Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease. Immunity. 2022;55:542\u2013e5565.","journal-title":"Immunity"},{"key":"4365_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bbi.2023.01.006","volume":"109","author":"C Franke","year":"2023","unstructured":"Franke C, Boesl F, Goereci Y, et al. Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome. Brain Behav Immun. 2023;109:139\u201343.","journal-title":"Brain Behav Immun"},{"key":"4365_CR14","first-page":"2200970","volume":"61","author":"K Son","year":"2023","unstructured":"Son K, Jamil R, Chowdhury A, et al. Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms. Eur Respir J. 2023;61:2200970.","journal-title":"Eur Respir J"},{"key":"4365_CR15","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1053\/j.gastro.2022.04.037","volume":"163","author":"A Zollner","year":"2022","unstructured":"Zollner A, Koch R, Jukic A, et al. Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases. Gastroenterology. 2022;163:495\u2013e5068.","journal-title":"Gastroenterology"},{"key":"4365_CR16","doi-asserted-by":"publisher","first-page":"e163669","DOI":"10.1172\/JCI163669","volume":"133","author":"MJ Peluso","year":"2023","unstructured":"Peluso MJ, Deveau T-M, Munter SE, et al. Chronic viral coinfections differentially affect the likelihood of developing long COVID. J Clin Invest. 2023;133:e163669.","journal-title":"J Clin Invest"},{"key":"4365_CR17","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1080\/17476348.2021.1916472","volume":"15","author":"SE Tanni","year":"2021","unstructured":"Tanni SE, Fabro AT, De Albuquerque A, et al. Pulmonary fibrosis secondary to COVID-19: a narrative review. Expert Rev Respir Med. 2021;15:791\u2013803.","journal-title":"Expert Rev Respir Med"},{"key":"4365_CR18","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1016\/j.neuron.2022.10.006","volume":"110","author":"M Monje","year":"2022","unstructured":"Monje M, Iwasaki A. The neurobiology of long COVID. Neuron. 2022;110:3484\u201396.","journal-title":"Neuron"},{"key":"4365_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ijcard.2021.07.033","volume":"340","author":"P Clavario","year":"2021","unstructured":"Clavario P, de Marzo V, Lotti R, et al. Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up. Int J Cardiol. 2021;340:113\u20138.","journal-title":"Int J Cardiol"},{"key":"4365_CR20","first-page":"2466789","volume":"2022","author":"G Evers","year":"2022","unstructured":"Evers G, Schulze AB, Osiaevi I, et al. Sustained Impairment in Cardiopulmonary Exercise Capacity Testing in Patients after COVID-19: A Single Center Experience. Can Respir J. 2022;2022:2466789.","journal-title":"Can Respir J"},{"key":"4365_CR21","doi-asserted-by":"publisher","unstructured":"Fr\u00e9sard I, Genecand L, Altarelli M, et al. Dysfunctional breathing diagnosed by cardiopulmonary exercise testing in long COVID patients with persistent dyspnoea. BMJ Open Respir Res. 2022;9. https:\/\/doi.org\/10.1136\/bmjresp-2021-001126.","DOI":"10.1136\/bmjresp-2021-001126"},{"key":"4365_CR22","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006944","author":"N Prasannan","year":"2022","unstructured":"Prasannan N, Heightman M, Hillman T, et al. Impaired exercise capacity in post-COVID syndrome: the role of VWF-ADAMTS13 axis. Blood Adv Published Online First. 2022. https:\/\/doi.org\/10.1182\/bloodadvances.2021006944.","journal-title":"Blood Adv Published Online First"},{"key":"4365_CR23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.chest.2021.08.010","volume":"161","author":"I Singh","year":"2022","unstructured":"Singh I, Joseph P, Heerdt PM, et al. Persistent Exertional Intolerance After COVID-19: Insights From Invasive Cardiopulmonary Exercise Testing. Chest. 2022;161:54\u201363.","journal-title":"Chest"},{"key":"4365_CR24","doi-asserted-by":"publisher","unstructured":"Skj\u00f8rten I, Ankerstjerne OAW, Trebinjac D, et al. Cardiopulmonary exercise capacity and limitations 3 months after COVID-19 hospitalisation. Eur Respir J. 2021;58. https:\/\/doi.org\/10.1183\/13993003.00996-2021.","DOI":"10.1183\/13993003.00996-2021"},{"key":"4365_CR25","doi-asserted-by":"publisher","first-page":"106577","DOI":"10.1016\/j.rmed.2021.106577","volume":"187","author":"RF Rinaldo","year":"2021","unstructured":"Rinaldo RF, Mondoni M, Parazzini EM, et al. Severity does not impact on exercise capacity in COVID-19 survivors. Respir Med. 2021;187:106577.","journal-title":"Respir Med"},{"key":"4365_CR26","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1378\/chest.122.3.920","volume":"122","author":"DL Lamping","year":"2002","unstructured":"Lamping DL, Schroter S, Marquis P, et al. The community-acquired pneumonia symptom questionnaire: a new, patient-based outcome measure to evaluate symptoms in patients with community-acquired pneumonia. Chest. 2002;122:920\u20139.","journal-title":"Chest"},{"key":"4365_CR27","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/MCP.0000000000000496","volume":"24","author":"C Hendriks","year":"2018","unstructured":"Hendriks C, Drent M, Elfferich M, et al. The Fatigue Assessment Scale: quality and availability in sarcoidosis and other diseases. Curr Opin Pulm Med. 2018;24:495\u2013503.","journal-title":"Curr Opin Pulm Med"},{"key":"4365_CR28","first-page":"147","volume":"69","author":"C-P Cri\u00e9e","year":"2015","unstructured":"Cri\u00e9e C-P, Baur X, Berdel D, et al. [Standardization of spirometry: 2015 update. Published by German Atemwegsliga, German Respiratory Society and German Society of Occupational and Environmental Medicine]. Pneumol Stuttg Ger. 2015;69:147\u201364.","journal-title":"Pneumol Stuttg Ger"},{"key":"4365_CR29","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1055\/s-2006-944245","volume":"60","author":"C-P Cri\u00e9e","year":"2006","unstructured":"Cri\u00e9e C-P, Berdel D, Heise D, et al. [Recommendations on spirometry by Deutsche Atemwegsliga]. Pneumol Stuttg Ger. 2006;60:576\u201384.","journal-title":"Pneumol Stuttg Ger"},{"key":"4365_CR30","first-page":"307","volume":"68","author":"H-J Kabitz","year":"2014","unstructured":"Kabitz H-J, Walterspacher S, Mellies U, et al. [Recommendations for respiratory muscle testing]. Pneumol Stuttg Ger. 2014;68:307\u201314.","journal-title":"Pneumol Stuttg Ger"},{"key":"4365_CR31","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2022","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2022. https:\/\/www.R-project.org\/."},{"key":"4365_CR32","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham H, Averick M, Bryan J, et al. Welcome to the tidyverse. J Open Source Softw. 2019;4:1686.","journal-title":"J Open Source Softw"},{"key":"4365_CR33","doi-asserted-by":"publisher","unstructured":"Bates D, M\u00e4chler M, Bolker B, et al. Fitting Linear Mixed-Effects Models Using lme4. J Stat Softw. 2015;67. https:\/\/doi.org\/10.18637\/jss.v067.i01.","DOI":"10.18637\/jss.v067.i01"},{"key":"4365_CR34","doi-asserted-by":"publisher","unstructured":"Kuznetsova A, Brockhoff PB, Christensen RHB. lmerTest Package: Tests in Linear Mixed Effects Models. J Stat Softw. 2017;82. https:\/\/doi.org\/10.18637\/jss.v082.i13.","DOI":"10.18637\/jss.v082.i13"},{"key":"4365_CR35","unstructured":"L\u00fcdecke D. sjPlot: Data Visualization for Statistics in Social Science. 2022. https:\/\/CRAN.R-project.org\/package=sjPlot."},{"key":"4365_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: Elegant Graphics for Data Analysis","author":"H Wickham","year":"2016","unstructured":"Wickham H. ggplot2: Elegant Graphics for Data Analysis. New York: Springer-; 2016. https:\/\/ggplot2.tidyverse.org."},{"key":"4365_CR37","unstructured":"Kassambara A. ggpubr: ggplot2 Based Publication Ready Plots. 2022. https:\/\/CRAN.R-project.org\/package=ggpubr."},{"key":"4365_CR38","unstructured":"Kassambara A. ggcorrplot: Visualization of a Correlation Matrix using ggplot2. 2022. https:\/\/CRAN.R-project.org\/package=ggcorrplot."},{"key":"4365_CR39","unstructured":"World Health Organisation. COVID-19 Clinical management. 2021. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/338882\/WHO-2019-nCoV-clinical-2021.1-eng.pdf."},{"key":"4365_CR40","doi-asserted-by":"publisher","unstructured":"Schilling J, Buda S, Tolksdorf K. Zweite Aktualisierung der \u201eRetrospektiven Phaseneinteilung der COVID-19- Pandemie in Deutschland. Published Online First: 10 March 2022. https:\/\/doi.org\/10.25646\/9787.","DOI":"10.25646\/9787"},{"key":"4365_CR41","volume-title":"Messung der Atemmuskelfunktion Empfehlungen der Deutschen Atemwegsliga e.V. in der Deutschen Gesellschaft f\u00fcr Pneumologie und Beatmungsmedizin (DGP)","author":"H-J Kabitz","year":"2014","unstructured":"Kabitz H-J. Messung der Atemmuskelfunktion Empfehlungen der Deutschen Atemwegsliga e.V. in der Deutschen Gesellschaft f\u00fcr Pneumologie und Beatmungsmedizin (DGP). M\u00fcnchen [i.e.] Deisenhofen: Dustri-Verl. Feistle; 2014."},{"key":"4365_CR42","first-page":"28","volume":"61","author":"J Karvonen","year":"1994","unstructured":"Karvonen J, Saarelainen S, Nieminen MM. Measurement of Respiratory Muscle Forces Based on Maximal Inspiratory and Expiratory Pressures. Respiration. 1994;61:28\u201331.","journal-title":"Respiration"},{"key":"4365_CR43","doi-asserted-by":"publisher","first-page":"180101","DOI":"10.1183\/16000617.0101-2018","volume":"28","author":"T Radtke","year":"2019","unstructured":"Radtke T, Crook S, Kaltsakas G, et al. ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases. Eur Respir Rev Off J Eur Respir Soc. 2019;28:180101.","journal-title":"Eur Respir Rev Off J Eur Respir Soc"},{"key":"4365_CR44","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1177\/01410768211032850","volume":"114","author":"OL Aiyegbusi","year":"2021","unstructured":"Aiyegbusi OL, Hughes SE, Turner G, et al. Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021;114:428\u201342.","journal-title":"J R Soc Med"},{"key":"4365_CR45","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/jmv.27309","volume":"94","author":"P Malik","year":"2022","unstructured":"Malik P, Patel K, Pinto C, et al. Post-acute COVID\u201019 syndrome (PCS) and health\u2010related quality of life (HRQoL)\u2014A systematic review and meta\u2010analysis. J Med Virol. 2022;94:253\u201362.","journal-title":"J Med Virol"},{"key":"4365_CR46","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1038\/s41591-022-01909-w","volume":"28","author":"A Subramanian","year":"2022","unstructured":"Subramanian A, Nirantharakumar K, Hughes S, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28:1706\u201314.","journal-title":"Nat Med"},{"key":"4365_CR47","doi-asserted-by":"publisher","first-page":"e2242106","DOI":"10.1001\/jamanetworkopen.2022.42106","volume":"5","author":"C Fern\u00e1ndez-de-Las-Pe\u00f1as","year":"2022","unstructured":"Fern\u00e1ndez-de-Las-Pe\u00f1as C, Rodr\u00edguez-Jim\u00e9nez J, Cancela-Cilleruelo I, et al. Post-COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients. JAMA Netw Open. 2022;5:e2242106.","journal-title":"JAMA Netw Open"},{"key":"4365_CR48","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1080\/02813432.2022.2139480","volume":"40","author":"L Adler","year":"2022","unstructured":"Adler L, Gazit S, Pinto Y, et al. Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study. Scand J Prim Health Care. 2022;40:342\u20139.","journal-title":"Scand J Prim Health Care"},{"key":"4365_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-024-02226-9","author":"KS Appel","year":"2024","unstructured":"Appel KS, N\u00fcrnberger C, Bahmer T, et al. Definition of the Post-COVID syndrome using a symptom-based Post-COVID score in a prospective, multi-center, cross-sectoral cohort of the German National Pandemic Cohort Network (NAPKON). Infection. Published Online First: 8 April. 2024. https:\/\/doi.org\/10.1007\/s15010-024-02226-9.","journal-title":"Published Online First: 8 April"},{"key":"4365_CR50","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bbi.2021.12.020","volume":"101","author":"F Ceban","year":"2022","unstructured":"Ceban F, Ling S, Lui LMW, et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun. 2022;101:93\u2013135.","journal-title":"Brain Behav Immun"},{"key":"4365_CR51","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.3390\/jcm11061541","volume":"11","author":"G Maglietta","year":"2022","unstructured":"Maglietta G, Diodati F, Puntoni M, et al. Prognostic Factors for Post-COVID-19 Syndrome: A Systematic Review and Meta-Analysis. J Clin Med. 2022;11:1541.","journal-title":"J Clin Med"},{"key":"4365_CR52","doi-asserted-by":"publisher","first-page":"00056","DOI":"10.1183\/23120541.00056-2022","volume":"8","author":"CC Huntley","year":"2022","unstructured":"Huntley CC, Patel K, Bil Bushra S-E-S, et al. Pulmonary function test and computed tomography features during follow-up after SARS, MERS and COVID-19: a systematic review and meta-analysis. ERJ Open Res. 2022;8:00056\u20132022.","journal-title":"ERJ Open Res"},{"key":"4365_CR53","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12931-022-02163-x","volume":"23","author":"JH Lee","year":"2022","unstructured":"Lee JH, Yim J-J, Park J. Pulmonary function and chest computed tomography abnormalities 6\u201312 months after recovery from COVID-19: a systematic review and meta-analysis. Respir Res. 2022;23:233.","journal-title":"Respir Res"},{"key":"4365_CR54","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41380-022-01614-7","volume":"28","author":"N Zeng","year":"2023","unstructured":"Zeng N, Zhao Y-M, Yan W, et al. A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action. Mol Psychiatry. 2023;28:423\u201333.","journal-title":"Mol Psychiatry"},{"key":"4365_CR55","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s15010-022-01840-9","volume":"50","author":"JK Hennigs","year":"2022","unstructured":"Hennigs JK, Huwe M, Hennigs A, et al. Respiratory muscle dysfunction in long-COVID patients. Infection. 2022;50:1391\u20137.","journal-title":"Infection"},{"key":"4365_CR56","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1159\/000527361","volume":"101","author":"C Nagel","year":"2022","unstructured":"Nagel C, Olschewski H, Sorichter S, et al. Impairment of Inspiratory Muscle Function after COVID-19. Respiration. 2022;101:981\u20139.","journal-title":"Respiration"},{"key":"4365_CR57","doi-asserted-by":"publisher","first-page":"00329","DOI":"10.1183\/23120541.00329-2022","volume":"9","author":"MN N\u00fa\u00f1ez-Seisdedos","year":"2023","unstructured":"N\u00fa\u00f1ez-Seisdedos MN, Valc\u00e1rcel-Linares D, G\u00f3mez-Gonz\u00e1lez MT, et al. Inspiratory muscle strength and function in mechanically ventilated COVID-19 survivors 3 and 6 months after intensive care unit discharge. ERJ Open Res. 2023;9:00329\u20132022.","journal-title":"ERJ Open Res"},{"key":"4365_CR58","doi-asserted-by":"publisher","first-page":"2103101","DOI":"10.1183\/13993003.03101-2021","volume":"60","author":"MA McNarry","year":"2022","unstructured":"McNarry MA, Berg RMG, Shelley J, et al. Inspiratory muscle training enhances recovery post-COVID-19: a randomised controlled trial. Eur Respir J. 2022;60:2103101.","journal-title":"Eur Respir J"},{"key":"4365_CR59","doi-asserted-by":"publisher","first-page":"jrm00330","DOI":"10.2340\/jrm.v54.3972","volume":"54","author":"EN Nagy","year":"2022","unstructured":"Nagy EN, Elimy DA, Ali AY, et al. Influence of Manual Diaphragm Release Technique Combined with Inspiratory Muscle Training on Selected Persistent Symptoms in Men with Post-Covid-19 Syndrome: A Randomized Controlled Trial. J Rehabil Med. 2022;54:jrm00330.","journal-title":"J Rehabil Med"},{"key":"4365_CR60","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12931-023-02602-3","volume":"25","author":"P Agostoni","year":"2024","unstructured":"Agostoni P, Mapelli M, Salvioni E, et al. Symptomatic post COVID patients have impaired alveolar capillary membrane function and high VE\/VCO2. Respir Res. 2024;25:82.","journal-title":"Respir Res"},{"key":"4365_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2021.07.007","author":"L Barbagelata","year":"2021","unstructured":"Barbagelata L, Masson W, Iglesias D, et al. Cardiopulmonary Exercise Testing in Patients with Post-COVID-19 Syndrome. Med Clin (Barc). Published Online First. 2021. https:\/\/doi.org\/10.1016\/j.medcli.2021.07.007.","journal-title":"Published Online First"},{"key":"4365_CR62","doi-asserted-by":"publisher","first-page":"e2236057","DOI":"10.1001\/jamanetworkopen.2022.36057","volume":"5","author":"MS Durstenfeld","year":"2022","unstructured":"Durstenfeld MS, Sun K, Tahir P, et al. Use of Cardiopulmonary Exercise Testing to Evaluate Long COVID-19 Symptoms in Adults: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022;5:e2236057.","journal-title":"JAMA Netw Open"},{"key":"4365_CR63","doi-asserted-by":"publisher","first-page":"e15850","DOI":"10.14814\/phy2.15850","volume":"11","author":"KL Nj\u00f8ten","year":"2023","unstructured":"Nj\u00f8ten KL, Espehaug B, Magnussen LH, et al. Relationship between exercise capacity and fatigue, dyspnea, and lung function in non-hospitalized patients with long COVID. Physiol Rep. 2023;11:e15850.","journal-title":"Physiol Rep"},{"key":"4365_CR64","doi-asserted-by":"publisher","first-page":"104062","DOI":"10.1016\/j.resp.2023.104062","volume":"313","author":"A Norweg","year":"2023","unstructured":"Norweg A, Yao L, Barbuto S, et al. Exercise intolerance associated with impaired oxygen extraction in patients with long COVID. Respir Physiol Neurobiol. 2023;313:104062.","journal-title":"Respir Physiol Neurobiol"},{"key":"4365_CR65","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.clnesp.2023.10.009","volume":"58","author":"R Ram\u00edrez-V\u00e9lez","year":"2023","unstructured":"Ram\u00edrez-V\u00e9lez R, Oscoz-Ochandorena S, Garc\u00eda-Alonso Y, et al. Maximal oxidative capacity during exercise is associated with muscle power output in patients with long coronavirus disease 2019 (COVID-19) syndrome. A moderation analysis. Clin Nutr ESPEN. 2023;58:253\u201362.","journal-title":"Clin Nutr ESPEN"},{"key":"4365_CR66","doi-asserted-by":"publisher","first-page":"106968","DOI":"10.1016\/j.rmed.2022.106968","volume":"202","author":"F Steinbeis","year":"2022","unstructured":"Steinbeis F, Knape P, Mittermaier M, et al. Functional limitations 12 months after SARS-CoV-2 infection correlate with initial disease severity: An observational study of cardiopulmonary exercise capacity testing in COVID-19 convalescents. Respir Med. 2022;202:106968.","journal-title":"Respir Med"},{"key":"4365_CR67","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3390\/life13030684","volume":"13","author":"M Sova","year":"2023","unstructured":"Sova M, Sovova E, Ozana J, et al. Post-COVID Syndrome and Cardiorespiratory Fitness\u201426-Month Experience of Single Center. Life. 2023;13:684.","journal-title":"Life"},{"key":"4365_CR68","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1093\/infdis\/jiac017","volume":"225","author":"Y Acosta-Ampudia","year":"2022","unstructured":"Acosta-Ampudia Y, Monsalve DM, Rojas M, et al. Persistent Autoimmune Activation and Proinflammatory State in Post-Coronavirus Disease 2019 Syndrome. J Infect Dis. 2022;225:2155\u201362.","journal-title":"J Infect Dis"},{"key":"4365_CR69","doi-asserted-by":"publisher","first-page":"e2424","DOI":"10.1002\/rmv.2424","volume":"33","author":"SJ Yong","year":"2023","unstructured":"Yong SJ, Halim A, Halim M, et al. Inflammatory and vascular biomarkers in post-COVID\u201019 syndrome: A systematic review and meta\u2010analysis of over 20 biomarkers. Rev Med Virol. 2023;33:e2424.","journal-title":"Rev Med Virol"},{"key":"4365_CR70","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.3390\/jcm9124039","volume":"9","author":"S Almuntashiri","year":"2020","unstructured":"Almuntashiri S, Zhu Y, Han Y, et al. Club Cell Secreted Protein CC16: Potential Applications in Prognosis and Therapy for Pulmonary Diseases. J Clin Med. 2020;9:4039.","journal-title":"J Clin Med"},{"key":"4365_CR71","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12931-022-01955-5","volume":"23","author":"O Sibila","year":"2022","unstructured":"Sibila O, Perea L, Albacar N, et al. Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge. Respir Res. 2022;23:37.","journal-title":"Respir Res"},{"key":"4365_CR72","doi-asserted-by":"publisher","first-page":"102107","DOI":"10.1016\/j.eclinm.2023.102107","volume":"62","author":"E Gentilotti","year":"2023","unstructured":"Gentilotti E, G\u00f3rska A, Tami A, et al. Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort. eClinicalMedicine. 2023;62:102107.","journal-title":"eClinicalMedicine"},{"key":"4365_CR73","doi-asserted-by":"publisher","first-page":"e048391","DOI":"10.1136\/bmjopen-2020-048391","volume":"11","author":"A Dennis","year":"2021","unstructured":"Dennis A, Wamil M, Alberts J, et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11:e048391.","journal-title":"BMJ Open"},{"key":"4365_CR74","doi-asserted-by":"publisher","first-page":"12422","DOI":"10.3390\/ijerph191912422","volume":"19","author":"P Gao","year":"2022","unstructured":"Gao P, Liu J, Liu M. Effect of COVID-19 Vaccines on Reducing the Risk of Long COVID in the Real World: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2022;19:12422.","journal-title":"Int J Environ Res Public Health"},{"key":"4365_CR75","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3390\/vaccines12020189","volume":"12","author":"MA Man","year":"2024","unstructured":"Man MA, Rosca D, Bratosin F, et al. Impact of Pre-Infection COVID-19 Vaccination on the Incidence and Severity of Post-COVID Syndrome: A Systematic Review and Meta-Analysis. Vaccines. 2024;12:189.","journal-title":"Vaccines"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04365-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04365-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04365-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:06:07Z","timestamp":1781669167000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04365-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4365"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04365-1","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"24 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AG reports personal fees for advisory board participation from GSK. CB reports research grants from Gilead Sciences GmbH and Goethe Corona Fonds (Goethe University Frankfurt am Main). MV reports research grants or contracts from MSD, Heel, BioNTech and Roche, consulting fees from MaaT, Tillots, MSD\/Merck, Roche, EUMEDICA, and payment or honoraria from Merck\/MSD, 3\u00a0M, Ferring, Astellas, Uniklinik Karlsruhe, Uniklinik K\u00f6ln, Akademie f\u00fcr Infektionsmedizin, Klinikum Essen, Pfizer, Universit\u00e4tsklinikum Heidelberg, Uniklinik Frankfurt, Landes\u00e4rztekammer Hessen, Janssen, Institut Merieux, Forum f\u00fcr medizinische Fortbildung GmbH, Universit\u00e4tsklinikum Freiburg, Berliner Dialy Seminar, ADKA, Falk Foundation, St. Johannes Hospital, DiaLog Service, CED Service, \u00c4rztekammer Niedersachsen, St. Josef Hospital, Limbach Grupe SE, SUMIT OXFORD Ltd. EUMDEICA Kit Kongress, Tillots Pharma, Helios Kliniken, Lahn-Dill-Kliniken, GILEAD, Klinikum Leverkusen. GR reports personal fees from Astra Zeneca, Atriva, Boehringer Ingelheim, GSK, Insmed, MSD, Sanofi, Novartis and Pfizer for consultancy during advisory board meetings, and personal fees from Astra Zeneca, Berlin Chemie, BMS, Boehringer Ingelheim, Chiesi, Essex Pharma, Grifols, GSK, Insmed, MSD, Roche, Sanofi, Solvay, Takeda, Novartis, Pfizer and Vertex for lectures including service on speakers bureaus. AS reports personal fees for advisory board participation from Sanofi Regeneron, GSK, Berlin Chemie and customer support from Boehringer Ingelheim and Broncus. All other authors report no potential conflict of interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"272"}}